Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Relatlimab in combination with nivolumab for advanced melanoma – second line	Nivolumab (Opdivo; BMS-936558; ONO-4538) , Relatlimab (BMS-986016; Anti-LAG-3)	Melanoma	Skin Cancer	2019	View \| Download
Relugolix combination therapy for treating endometriosis-associated pain	Relugolix (TAK-385)	Endometriosis-associated pain	Gynaecology and Obstetrics , Pain Relief	2021	View \| Download
Relugolix for treating advanced hormone-sensitive prostate cancer	Relugolix (TAK-385)	Prostate cancer	Male Reproductive Cancer	2022	View \| Download
Relugolix in combination with estradiol/norethindrone acetate for moderate to severe symtpoms of uterine fibroids	Relugolix (TAK-385)	Heavy menstrual bleeding	Gynaecology and Obstetrics	2020	View \| Download
Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines	Remibrutini (LOU064)	Chronic spontaneous urticaria (CSU)	Dermatology	2023	View \| Download
Remimazolam for general anaesthesia – first line	Remimazolam (CNS 7056; ONO-2745)	Anaesthesia	Neurology	2020	View \| Download
Remimazolam for procedural sedation	Remimazolam (CNS 7056; ONO-2745)	Procedural sedation	Neurology	2020	View \| Download
Repotrectinib for treating advanced or metastatic nonsmall-cell lung cancer with ROS1-postive mutation	Repotrectinib (TPX 0005)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Resmetirom for non-alcoholic steatohepatitis	Resmetirom (MGL-3196)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2023	View \| Download
Resminostat for maintenance treatment of patients with advanced stage mycosis fungoides or Sézary syndrome	Resminostat (4SC-201)	Cutaneous T-cell lymphoma (CTCL) , Mycosis fungoides or sezary syndrome	Haematological Cancer and Lymphomas , Skin Cancer	2024	View \| Download